Overall impact
C (57)

Commentary

Omnicell is an average overall performer. With a 'C' rating of 57.0 for overall impact (56th percentile compared to all companies), Omnicell ranks 65th out of 96 industry peers, behind Suvoda, Gainwell Technologies, Healthequity and 61 others, and ahead of Maximus, Bionano Genomics, Progyny and 28 others. On top material causes for Omnicell's industry (Healthcare Software & Services), Omnicell performs well in Equal Pay and Opportunity (85.6 score) and Free, Secure Flow of Information (82.8) and performs poorly in Disease Eradication (37.2 score), Racial Justice and Civil Rights (19.0), Access to Affordable Healthcare (33.9) and 1 other cause where it received a 'D' or 'F' score.
Impact
Cause OMCL
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Employees
3,620
Sector
Health Care
Industry
Health Care Providers & Services
Sub-industry
Health Care Services
SASB industry
Software & IT Services
Headquarters
Tx, United States
Share classes
OMCL
Description
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies in the United States and internationally. The company offers point of care automation solutions to improve clinician workflows; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital; and specialized automated dispensing systems for hospitals, health systems, and post-acute care facilities. It also provides central pharmacy dispensing services; IV compounding services; and a turnkey solution designed to help health systems establish, manage, and optimize an entity-owned specialty pharmacy. This includes support for onsite management of specialty pharmacy services, such as payer contracting, staffing, licensing, and 340B program administration. In addition, the company offers inventory optimization services comprising predictive and prescriptive analytics, benchmarking, workflow tools, and clinical resources, as well as medication inventory visibility. Other offerings include patient engagement, clinical, and financial solutions; medication adherence solutions, which encompass single-dose automation solutions, automated and semi-automated filling equipment, various medication blister card packaging, and packaging supplies; and software that guides users through the manual filling process. Further, it provides professional services, such as technology installation, program management, customer education and training, change management services, and related offerings. The company also offers technical services comprising post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades, as well as retail pharmacy and hospital automation outside the United States business. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. It was incorporated in 1992 and is headquartered in Fort Worth, Texas.
Material causes
Ethos considers the following causes material for Omnicell, based on its industry sub-industry Health Care Services. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.